From Our Partners
Monday, June 27, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

High Consequence Livestock Disease Technology Commercialization

by Global Biodefense Staff
November 30, 2015

The Texas A&M College of Veterinary Medicine & Biomedical Sciences (CVM) and the Institute for Infectious Animal Diseases (IIAD) have been awarded a $1.2 million Department of Homeland Security (DHS) Science and Technology contract to develop and implement a nationwide scientific business development and management educational program.

The successfully funded proposal is titled “From the Bench to the Shop: Creation and Implementation of a Scientific Business Development and Management Program to Transition High Consequence Livestock Disease Research and Development Technologies for Commercialization.”

DHS invited the submission of proposals with innovative approaches to develop training programs for preparing animal disease scientists to respond against these diseases.

Awarded proposals support preparation for the U.S. National Bio and Agro-Defense Facility (NBAF) new state-of-the-art biocontainment facility, which will study emerging transboundary animal diseases that threaten animal agriculture and public health. This new facility will replace DHS’s Plum Island Animal Disease Center in 2022.

Texas A&M’s project will develop a novel training curriculum to equip next generation scientific professionals with the skill sets required to transition research discoveries to the marketplace.

“As a whole, this program will be vital to workforce development in the U.S.—particularly for the new NBAF,” said Gerald Parker, DVM, Ph.D., M.S., IIAD interim director. “It will truly focus on soft skill sets and commercialization, teaching researchers how to take their product where it needs to go for widespread commercial adoption and success.”

The program is being developed using a large-scale national and international consortium of federal partners, industry, international groups, and academia. Development of such a program requires a multidisciplinary partnership from multiple groups and organizations for trainees to understand the entire skill set required to take a research and development product to commercialization.

This program will be based at Texas A&M University in College Station, Texas and involves a wide team of partners, which includes Colorado State University, University of Texas Medical Branch in Galveston, Kansas State University, and Agricultural Research Council-Onderstepoort Veterinary Institute in South Africa.

“This project is a major undertaking and promises to be successful because of its collaborative, multidisciplinary nature,” said Craig Nessler, Ph.D., Texas A&M AgriLife Research director. “This is a first of its kind and has brought together a team with the proven track records, skills, and commitment. This project supports the goals of Texas A&M AgriLife Research.

Source: Institute for Infectious Animal Diseases, adapted.

From Our Partners
Tags: Agro-DefenseAwards

Related Posts

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC